NasdaqGS - Delayed Quote • USD
Medpace Holdings, Inc. (MEDP)
At close: April 24 at 4:00 PM EDT
After hours: April 24 at 7:23 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 6 | 6 | 7 | 7 |
| Avg. Estimate | 2.52 | 2.71 | 11 | 12.84 |
| Low Estimate | 2.43 | 2.63 | 10.56 | 11.97 |
| High Estimate | 2.59 | 2.78 | 11.41 | 13.45 |
| Year Ago EPS | 1.93 | 2.22 | 8.88 | 11 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 6 | 6 | 7 | 7 |
| Avg. Estimate | 532.42M | 558.69M | 2.18B | 2.53B |
| Low Estimate | 530M | 551.74M | 2.16B | 2.45B |
| High Estimate | 540.17M | 564.28M | 2.2B | 2.64B |
| Year Ago Sales | 460.87M | 492.5M | 1.89B | 2.18B |
| Sales Growth (year/est) | 15.50% | 13.40% | 15.50% | 16.10% |
Earnings History
| CURRENCY IN USD | 6/30/2023 | 9/30/2023 | 12/31/2023 | 3/31/2024 |
|---|---|---|---|---|
| EPS Est. | 1.91 | 2.05 | 2.22 | 2.46 |
| EPS Actual | 1.93 | 2.22 | 2.46 | 3.2 |
| Difference | 0.02 | 0.17 | 0.24 | 0.74 |
| Surprise % | 1.00% | 8.30% | 10.80% | 30.10% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 2.52 | 2.71 | 11 | 12.84 |
| 7 Days Ago | 2.53 | 2.71 | 10.61 | 12.69 |
| 30 Days Ago | 2.53 | 2.71 | 10.62 | 12.68 |
| 60 Days Ago | 2.53 | 2.72 | 10.54 | 12.73 |
| 90 Days Ago | 2.41 | 2.56 | 9.96 | 11.84 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | 3 | 2 | 4 | 3 |
| Up Last 30 Days | 4 | 2 | 4 | 3 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | 1 | 1 | -- | 1 |
Growth Estimates
| CURRENCY IN USD | MEDP | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 30.60% | -- | -- | 1.50% |
| Next Qtr. | 22.10% | -- | -- | 11.40% |
| Current Year | 23.90% | -- | -- | 5.20% |
| Next Year | 16.70% | -- | -- | 13.40% |
| Next 5 Years (per annum) | 17.91% | -- | -- | 11.09% |
| Past 5 Years (per annum) | 31.46% | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Maintains | Guggenheim: Buy to Buy | 4/24/2024 |
| Maintains | Baird: Outperform to Outperform | 4/24/2024 |
| Upgrade | Jefferies: Hold to Buy | 4/23/2024 |
| Initiated | Deutsche Bank: Hold | 3/18/2024 |
| Maintains | UBS: Buy to Buy | 3/8/2024 |
| Upgrade | UBS: Neutral to Buy | 2/15/2024 |
Related Tickers
IDXX IDEXX Laboratories, Inc.
494.26
+0.09%
TMO Thermo Fisher Scientific Inc.
577.39
+0.49%
DHR Danaher Corporation
250.41
-1.07%
ICLR ICON Public Limited Company
309.44
+0.98%
MTD Mettler-Toledo International Inc.
1,235.37
-0.48%
DGX Quest Diagnostics Incorporated
137.55
+0.62%
IQV IQVIA Holdings Inc.
240.84
+0.93%
WAT Waters Corporation
310.25
-0.97%
GH Guardant Health, Inc.
18.10
+4.38%
CRL Charles River Laboratories International, Inc.
239.43
-0.29%